Mainstream

Y-mAbs Therapeutics GAAP EPS of -$0.07 beats by $0.19, revenue of $19.53M beats by $1.13M

Y-mAbs Therapeutics GAAP EPS of -$0.07 beats by $0.19, revenue of $19.53M beats by $1.13M

Post ContentymabRead More

You might also be interested in reading Grayscale Releases Smart Contract Platform Fund.

August 8, 2025
In Mainstream